Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q57548973
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241120235810.0 |
008
|
|
|
241120nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q57548973
|
024
|
|
|
‡a
0000-0002-5007-6674
‡2
orcid
|
035
|
|
|
‡a
(OCoLC)Q57548973
|
100
|
0 |
|
‡a
Paul Simons
‡c
researcher ORCID ID = 0000-0002-5007-6674
‡9
en
|
375
|
|
|
‡a
1
‡2
iso5218
|
400
|
0 |
|
‡a
Paul Simons
‡c
wetenschapper
‡9
nl
|
670
|
|
|
‡a
Author's A role for APP in Wnt signalling links synapse loss with β-amyloid production
|
670
|
|
|
‡a
Author's A specific nanobody prevents amyloidogenesis of D76N β2-microglobulin in vitro and modifies its tissue distribution in vivo.
|
670
|
|
|
‡a
Author's Adeno-associated virus serotypes 7 and 8 outperform serotype 9 in expressing atheroprotective human apoE3 from mouse skeletal muscle.
|
670
|
|
|
‡a
Author's Amyloid persistence in decellularized liver: biochemical and histopathological characterization.
|
670
|
|
|
‡a
Author's Amyloid β synaptotoxicity is Wnt-PCP dependent and blocked by fasudil.
|
670
|
|
|
‡a
Author's C-reactive protein is essential for innate resistance to pneumococcal infection
|
670
|
|
|
‡a
Author's Class I Major Histocompatibility Complex, the Trojan Horse for Secretion of Amyloidogenic β 2 -Microglobulin
|
670
|
|
|
‡a
Author's Clusterin regulates β-amyloid toxicity via Dickkopf-1-driven induction of the wnt-PCP-JNK pathway
|
670
|
|
|
‡a
Author's Exon skipping of hepatic APOB pre-mRNA with splice-switching oligonucleotides reduces LDL cholesterol in vivo.
|
670
|
|
|
‡a
Author's Loss of phosphatidylinositol 4-kinase 2 Alpha activity causes late onset degeneration of spinal cord axons
|
670
|
|
|
‡a
Author's Notch controls embryonic Schwann cell differentiation, postnatal myelination and adult plasticity.
|
670
|
|
|
‡a
Author's Oligonucleotide-directed gene-editing technology: mechanisms and future prospects.
|
670
|
|
|
‡a
Author's Overexpression of 5-HT2C receptors in forebrain leads to elevated anxiety and hypoactivity.
|
670
|
|
|
‡a
Author's Pathogenetic mechanisms of amyloid A amyloidosis.
|
670
|
|
|
‡a
Author's Pharmacological removal of serum amyloid P component from intracerebral plaques and cerebrovascular Aβ amyloid deposits in vivo
|
670
|
|
|
‡a
Author's Reducing β-amyloid by inhibition of BACE1: how low should you go?
|
670
|
|
|
‡a
Author's Screening for mutations in the phosphatidylinositol 4-kinase 2- Alpha gene in autosomal recessive hereditary spastic paraplegia.
|
670
|
|
|
‡a
Author's Systemic exosomal siRNA delivery reduced Alpha -synuclein aggregates in brains of transgenic mice
|
670
|
|
|
‡a
Author's The effects of short-term JNK inhibition on the survival and growth of aged sympathetic neurons.
|
670
|
|
|
‡a
Author's The IGF-I splice variant MGF increases progenitor cells in ALS, dystrophic, and normal muscle
|
670
|
|
|
‡a
Author's Type II PI4-kinases control Weibel-Palade body biogenesis and von Willebrand factor structure in human endothelial cells
|
670
|
|
|
‡a
Author's Validation of oligonucleotide-mediated gene editing.
|
909
|
|
|
‡a
(orcid) 0000000250076674
‡9
1
|
919
|
|
|
‡a
amyloidβsynaptotoxicityiswntpcpdependentandblockedbyfasudil
‡A
Amyloid β synaptotoxicity is Wnt-PCP dependent and blocked by fasudil.
‡9
1
|
919
|
|
|
‡a
adenoassociatedvirusserotypes7and8outperformserotype9inexpressingatheroprotectivehumanapoe3frommouseskeletalmuscle
‡A
Adeno-associated virus serotypes 7 and 8 outperform serotype 9 in expressing atheroprotective human apoE3 from mouse skeletal muscle.
‡9
1
|
919
|
|
|
‡a
specificnanobodypreventsamyloidogenesisofd76nβ2microglobulininvitroandmodifiesitstissuedistributioninvivo
‡A
A specific nanobody prevents amyloidogenesis of D76N β2-microglobulin in vitro and modifies its tissue distribution in vivo.
‡9
1
|
919
|
|
|
‡a
roleforappinwntsignallinglinkssynapselosswithβamyloidproduction
‡A
A role for APP in Wnt signalling links synapse loss with β-amyloid production
‡9
1
|
919
|
|
|
‡a
lossofphosphatidylinositol4kinase2 Alpha activitycauseslateonsetdegenerationofspinalcordaxons
‡A
Loss of phosphatidylinositol 4-kinase 2 Alpha activity causes late onset degeneration of spinal cord axons
‡9
1
|
919
|
|
|
‡a
notchcontrolsembryonicschwanncelldifferentiationpostnatalmyelinationandadultplasticity
‡A
Notch controls embryonic Schwann cell differentiation, postnatal myelination and adult plasticity.
‡9
1
|
919
|
|
|
‡a
oligonucleotidedirectedgeneeditingtechnologymechanismsandfutureprospects
‡A
Oligonucleotide-directed gene-editing technology: mechanisms and future prospects.
‡9
1
|
919
|
|
|
‡a
overexpressionof5ht2creceptorsinforebrainleadstoelevatedanxietyandhypoactivity
‡A
Overexpression of 5-HT2C receptors in forebrain leads to elevated anxiety and hypoactivity.
‡9
1
|
919
|
|
|
‡a
pathogeneticmechanismsofamyloidaamyloidosis
‡A
Pathogenetic mechanisms of amyloid A amyloidosis.
‡9
1
|
919
|
|
|
‡a
pharmacologicalremovalofserumamyloidpcomponentfromintracerebralplaquesandcerebrovascularaβamyloiddepositsinvivo
‡A
Pharmacological removal of serum amyloid P component from intracerebral plaques and cerebrovascular Aβ amyloid deposits in vivo
‡9
1
|
919
|
|
|
‡a
reducingβamyloidbyinhibitionofbace1howlowshouldyou5
‡A
Reducing β-amyloid by inhibition of BACE1: how low should you go?
‡9
1
|
919
|
|
|
‡a
screeningformutationsinthephosphatidylinositol4kinase2 Alpha geneinautosomalrecessivehereditaryspasticparaplegia
‡A
Screening for mutations in the phosphatidylinositol 4-kinase 2- Alpha gene in autosomal recessive hereditary spastic paraplegia.
‡9
1
|
919
|
|
|
‡a
systemicexosomalsirnadeliveryreduced Alpha synucleinaggregatesinbrainsoftransgenicmice
‡A
Systemic exosomal siRNA delivery reduced Alpha -synuclein aggregates in brains of transgenic mice
‡9
1
|
919
|
|
|
‡a
effectsofshorttermjnkinhibitiononthesurvivalandgrowthofagedsympatheticneurons
‡A
The effects of short-term JNK inhibition on the survival and growth of aged sympathetic neurons.
‡9
1
|
919
|
|
|
‡a
igf1splicevariantmgfincreasesprogenitorcellsinalsdystrophicandnormalmuscle
‡A
The IGF-I splice variant MGF increases progenitor cells in ALS, dystrophic, and normal muscle
‡9
1
|
919
|
|
|
‡a
type2pi4kinasescontrolweibelpaladebodybiogenesisandvonwillebrandfactorstructureinhumanendothelialcells
‡A
Type II PI4-kinases control Weibel-Palade body biogenesis and von Willebrand factor structure in human endothelial cells
‡9
1
|
919
|
|
|
‡a
validationofoligonucleotidemediatedgeneediting
‡A
Validation of oligonucleotide-mediated gene editing.
‡9
1
|
919
|
|
|
‡a
amyloidpersistenceindecellularizedliverbiochemicalandhistopathologicalcharacterization
‡A
Amyloid persistence in decellularized liver: biochemical and histopathological characterization.
‡9
1
|
919
|
|
|
‡a
clusterinregulatesβamyloidtoxicityviadickkopf1driveninductionofthewntpcpjnkpathway
‡A
Clusterin regulates β-amyloid toxicity via Dickkopf-1-driven induction of the wnt-PCP-JNK pathway
‡9
1
|
919
|
|
|
‡a
exonskippingofhepaticapobpremrnawithspliceswitchingoligonucleotidesreducesldlcholesterolinvivo
‡A
Exon skipping of hepatic APOB pre-mRNA with splice-switching oligonucleotides reduces LDL cholesterol in vivo.
‡9
1
|
919
|
|
|
‡a
class1majorhistocompatibilitycomplexthetrojanhorseforsecretionofamyloidogenicβ2microglobulin
‡A
Class I Major Histocompatibility Complex, the Trojan Horse for Secretion of Amyloidogenic β 2 -Microglobulin
‡9
1
|
919
|
|
|
‡a
100reactiveproteinisessentialforinnateresistancetopneumococcalinfection
‡A
C-reactive protein is essential for innate resistance to pneumococcal infection
‡9
1
|
946
|
|
|
‡a
b
‡9
1
|
996
|
|
|
‡2
SUDOC|109208846
|
996
|
|
|
‡2
BNE|XX1073197
|
996
|
|
|
‡2
ISNI|0000000392806484
|
996
|
|
|
‡2
BIBSYS|1067280
|
996
|
|
|
‡2
DNB|1220250295
|
996
|
|
|
‡2
NII|DA13119731
|
996
|
|
|
‡2
ISNI|0000000389726694
|
996
|
|
|
‡2
NUKAT|n 2005110975
|
996
|
|
|
‡2
NKC|mzk2010590196
|
996
|
|
|
‡2
NTA|121712990
|
996
|
|
|
‡2
LC|nb2020008760
|
996
|
|
|
‡2
NTA|160265894
|
996
|
|
|
‡2
BLBNB|000540683
|
996
|
|
|
‡2
BIBSYS|90408389
|
996
|
|
|
‡2
ISNI|0000000109786781
|
996
|
|
|
‡2
DNB|1070943231
|
996
|
|
|
‡2
NSK|000432342
|
996
|
|
|
‡2
DNB|117398047
|
996
|
|
|
‡2
LC|nb2008007780
|
996
|
|
|
‡2
PLWABN|9810560251205606
|
996
|
|
|
‡2
ISNI|0000000082781437
|
996
|
|
|
‡2
NTA|070807671
|
996
|
|
|
‡2
ISNI|0000000396118064
|
996
|
|
|
‡2
SUDOC|242140963
|
996
|
|
|
‡2
LC|n 2006067308
|
996
|
|
|
‡2
ISNI|0000000389450851
|
996
|
|
|
‡2
ISNI|0000000391194527
|
996
|
|
|
‡2
NTA|136330398
|
996
|
|
|
‡2
NTA|266562558
|
996
|
|
|
‡2
J9U|987007422744005171
|
996
|
|
|
‡2
RERO|A003833835
|
996
|
|
|
‡2
DNB|1073253554
|
996
|
|
|
‡2
ISNI|0000000387402688
|
996
|
|
|
‡2
NTA|197115233
|
996
|
|
|
‡2
DNB|1022881930
|
996
|
|
|
‡2
LC|nb2014013130
|
996
|
|
|
‡2
NTA|075177773
|
996
|
|
|
‡2
ISNI|0000000038217310
|
996
|
|
|
‡2
LC|n 90636933
|
996
|
|
|
‡2
SUDOC|227099397
|
996
|
|
|
‡2
NTA|073820008
|
996
|
|
|
‡2
ISNI|000000036886465X
|
996
|
|
|
‡2
NII|DA06757523
|
996
|
|
|
‡2
LC|nb2007028145
|
996
|
|
|
‡2
PTBNP|1454926
|
996
|
|
|
‡2
NDL|00516230
|
996
|
|
|
‡2
ISNI|000000039231579X
|
996
|
|
|
‡2
DNB|1224845137
|
996
|
|
|
‡2
NTA|072479345
|
996
|
|
|
‡2
ISNI|0000000067719264
|
996
|
|
|
‡2
BIBSYS|90721005
|
996
|
|
|
‡2
LC|no2014101923
|
996
|
|
|
‡2
ISNI|0000000396205061
|
996
|
|
|
‡2
ISNI|0000000394171523
|
996
|
|
|
‡2
LC|n 88621394
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|